You're reading the free version. Trader adds the live tape and alerts.
Start tracking
MNPR Sale Disclosure
Anderson Raymond · SEC Form 4 · Filed Aug 28, 2026
Sale
Calculated transaction value
$76.37K
Anderson Raymond Director
MNPR
Monopar Therapeutics
MNPR
Transaction date
Aug 25, 2026
Public filing date
Aug 28, 2026
Filing lag
Filed 3 days later
MNPR daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 694 shares @ $110.04
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4/A
- Filing identifier
- 0001437749-26-029228
Filing cohort
Transactions in this filing
Showing 7 of 7
Trades
7
Issuers
1
Estimated value
$446.1K
Buys / sales
0 / 3
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Monopar Therapeutics MNPR | Sale | Aug 25, 2026 | $203.72K |
| Monopar Therapeutics MNPR | Exercise | Aug 25, 2026 | $0 |
| Monopar Therapeutics MNPR | Exercise | Aug 25, 2026 | $0 |
| Monopar Therapeutics MNPR Current | Sale | Aug 25, 2026 | $76.37K |
| Monopar Therapeutics MNPR | Exercise | Aug 25, 2026 | $42.06K |
| Monopar Therapeutics MNPR | Exercise | Aug 25, 2026 | $52.2K |
| Monopar Therapeutics MNPR | Sale | Aug 25, 2026 | $71.75K |